
Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia
Keywords: سیتوکروم پی۴۵۰; AUC; Area under curve; BMI; body mass index; CYP; Cytochrome P450; DMO; N-desmethyl-olanzapine; MS; metabolic syndrome; OLZ; olanzapine; ROC; receiver operator characteristic; TDM; therapeutic drug monitoring; Olanzapine; N-desmethy-olanzapine; Schizophre